At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Rakesh Sahay discusses the challenges of management of patients living with type 2 diabetes. This is part two of his interview, part one can be viewed here.
Questions:
1. Where do sulfonylureas fit into the current treatment paradigm for T2D? (0:04)
2. What are you most looking forward to at this year’s EASD? (2:37)
Rakesh Sahay is an Advisory board member to Sanofi, Novo, Lily
Filmed at the Annual Meeting of the European Association of the Study of Diabetes (EASD) Barcelona, Spain 2019.
